Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

Cyted Health develops minimally invasive diagnostic tests for gastrointestinal disease, combining cell collection devices with molecular biomarkers to detect conditions earlier.